BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19196217)

  • 21. Specific binding sites for gonadotrophin-releasing hormone, LH/chorionic gonadotrophin, low-density lipoprotein, prolactin and FSH in homogenates of human corpus luteum. II: Concentrations throughout the luteal phase of the menstrual cycle and early pregnancy.
    Bramley TA; Stirling D; Swanston IA; Menzies GS; McNeilly AS; Baird DT
    J Endocrinol; 1987 May; 113(2):317-27. PubMed ID: 3035053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human chorionic gonadotropin as a measure of pregnancy duration.
    Larsen J; Buchanan P; Johnson S; Godbert S; Zinaman M
    Int J Gynaecol Obstet; 2013 Dec; 123(3):189-95. PubMed ID: 24079475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization.
    Manau D; Fábregues F; Arroyo V; Jiménez W; Vanrell JA; Balasch J
    Fertil Steril; 2002 Dec; 78(6):1261-7. PubMed ID: 12477522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult biochemical pregnancy: fact or fiction?
    Walker EM; Lewis M; Cooper W; Marnie M; Howie PW
    Br J Obstet Gynaecol; 1988 Jul; 95(7):659-63. PubMed ID: 3273753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma volume expansion in early pregnancy.
    Bernstein IM; Ziegler W; Badger GJ
    Obstet Gynecol; 2001 May; 97(5 Pt 1):669-72. PubMed ID: 11339913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in adenylyl cyclase activity of the human and nonhuman primate corpus luteum during the menstrual cycle and pregnancy.
    Rojas FJ; Moretti-Rojas IM; Balmaceda JP; Asch RH
    J Clin Endocrinol Metab; 1989 Feb; 68(2):379-85. PubMed ID: 2537330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteinizing hormone-releasing hormone and the human menstrual cycle.
    Aksel S
    Am J Obstet Gynecol; 1979 Sep; 135(1):96-101. PubMed ID: 382857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between ovarian steroids, gonadotrophins and relaxin during the menstrual cycle.
    Johnson MR; Carter G; Grint C; Lightman SL
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):121-5. PubMed ID: 8372595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.
    Beckers NG; Laven JS; Eijkemans MJ; Fauser BC
    Hum Reprod; 2000 Jan; 15(1):43-9. PubMed ID: 10611186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
    Cameron IT; Baird DT
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum.
    Ottobre JS; Stouffer RL
    Endocrinology; 1984 Jun; 114(6):2175-82. PubMed ID: 6723578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The normal variabilities of the menstrual cycle.
    Cole LA; Ladner DG; Byrn FW
    Fertil Steril; 2009 Feb; 91(2):522-7. PubMed ID: 18433748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual deviations in human chorionic gonadotropin concentrations during pregnancy.
    Cole LA
    Am J Obstet Gynecol; 2011 Apr; 204(4):349.e1-7. PubMed ID: 21324434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chorionic gonadotropin in women fitted with intrauterine device.
    Yarkoni S; Zer TA; Schenker JG
    Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in in vitro fertilization cycles.
    Ayoubi JM; Epiney M; Brioschi PA; Fanchin R; Chardonnens D; de Ziegler D
    Fertil Steril; 2003 May; 79(5):1101-5. PubMed ID: 12738502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.
    Gonen Y; Balakier H; Powell W; Casper RF
    J Clin Endocrinol Metab; 1990 Oct; 71(4):918-22. PubMed ID: 2119392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.